Communiqués Bio-Rad Laboratories, Inc.

Actions

BIO

US0905722072

Equipement, fournitures et distribution médicale

Temps réel estimé Cboe BZX Autres places de cotation 16:27:26 29/07/2026			Varia. 5j.	Varia. 1 janv.
333,86 ^USD	+0,86 %		+9,23 %	+10,30 %

01/07	Les investisseurs activistes intensifient leurs campagnes au premier semestre et privilégient les fusions-acquisitions	RE
03/06	Transcript : Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM

Communiqués

23/07	Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026	BU
11/05	Bio-Rad to Participate in Upcoming Investor Conferences	AQ
08/05	Bio-Rad to Participate in Upcoming Investor Conferences	BU
01/05	Bio Rad Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
30/04	Bio-Rad: Q1 Earnings Snapshot	AQ
30/04	Bio-Rad Reports First-Quarter 2026 Financial Results	BU
16/04	Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026	BU
12/02	Bio-Rad: Q4 Earnings Snapshot	AQ
12/02	Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results	BU
29/01	Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026	BU
06/01	Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference	BU
29/10/25	Bio-Rad: Q3 Earnings Snapshot	AQ
29/10/25	Bio-Rad Reports Third-Quarter 2025 Financial Results	BU
16/10/25	Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025	BU
30/09/25	Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away	BU
25/08/25	Bio-Rad's Management to Participate in Upcoming Investor Conferences	BU
04/08/25	Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025	AQ
01/08/25	Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025	BU
31/07/25	Bio-Rad: Q2 Earnings Snapshot	AQ
31/07/25	Bio-Rad Reports Second-Quarter 2025 Financial Results	BU
28/07/25	Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations	BU
17/07/25	Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025	BU
07/07/25	Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout	BU
29/05/25	Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference	BU
12/05/25	Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference	BU